The Patent Finder

Spyglass Pharma, Inc.

9 patents currently held · Updated Nov 17, 2026
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Spyglass Ophthalmics, Inc. (to 2021)

0
Ending by 2030
Jul 2039
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 14, 2027
    The maintenance fee for Intraocular Drug Delivery Platform (US 11,813,159) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jul 30, 2027
    The maintenance fee for Iol with Drug Delivery Devices and Uninterrupted Pco Barrier Edge (US 11,883,277) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
  • 1 fee due Aug 20, 2027
    The maintenance fee for Ophthalmic Implant System for Drug Delivery (US 11,903,874) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

PatentTitleStatus Expires Confidence
US 11,298,262Ophthalmic Device For Drug Delivery
In force
 · High confidence
In forceHigh confidence
US 12,533,257Ophthalmic Device for Drug Delivery
In force
 · Medium confidence
In forceMedium confidence
US 11,617,681Ophthalmic Implant System for Drug Delivery
In force
 · Medium confidence
In forceMedium confidence
US 11,903,874Ophthalmic Implant System for Drug Delivery
In force
 · High confidence
In forceHigh confidence
US 11,399,977Ophthalmic Implant System for Drug Delivery
In force
 · High confidence
In forceHigh confidence
US 11,654,014Iol with Drug Delivery Devices and Uninterrupted Pco Barrier Edge
In force
 · Medium confidence
In forceMedium confidence
US 11,883,277Iol with Drug Delivery Devices and Uninterrupted Pco Barrier Edge
In force
 · Low confidence
In forceLow confidence
US 12,161,548Intraocular Drug Delivery Platform
In force
 · Medium confidence
In forceMedium confidence
US 11,813,159Intraocular Drug Delivery Platform
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 7 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 2 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited